Navigation Links
Aldosterone, Serum

ProductsAldosterone, Serum
Company ARUP Laboratories
Item Aldosterone, Serum
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Aldosterone, Urine
2. SAFE-T-FILL Serum
3. SAFE-T-FILL Serum Mini Capillary Collection Tubes
4. SAFE-T-FILL Serum Gel Mini Capillary Collection Tubes
5. SAFE-T-FILL Serum Gel Capillary Collection Tubes
6. SAFE-T-FILL Serum Bili
7. SAFE-T-FILL Serum Bili Gel Capillary Collection Tubes
8. Lyphochek Maternal Serum Control
9. Liquichek Serum Volatiles Control
10. Lyphochek Drug-Free Serum
11. hCG Combo Urine/Serum - Rapid Test
The DELFIA Platewash is a general purpose microtitration plate and strip washer especially standardized for use with DELFIA diagnostic kits....
... DW4 liquid handling system from Molecular Devices ... in one instrument. The system handles a ... plate washing96-, 384- and 1536-welland is the ... DW4 has been optimized to dispense from ...
... washers available to handle multiple ... assays. Embla 384 Cell washer ... been optimized to avoid cell ... compatible and have been integrated ...
Space-saving counter top model,User initiated manual defrost,Standard features (see above),Internal freezing compartment,Removable half-shelf in refrigerator,Two shelves in door,UL 471 Commercial Ref...
Medicine Products:
(Date:6/1/2015)... Garden City, NY (PRWEB) June 02, 2015 ... (NAPW) honors Kathy Everette-Gaines as a 2015-2016 inductee ... She is recognized with this prestigious distinction for ... networking organization exclusively for professional women, boasting more ... Chapters. , “I’m pleased to welcome Kathy into ...
(Date:6/1/2015)... (PRWEB) June 02, 2015 The ... Lenita F. Cornett, DSL, LSSBB (C), First Sergeant A ... VIP Woman of the Year Circle. She is recognized ... NAPW is the nation's leading networking organization exclusively for ... 200 operating Local Chapters. , “I'm pleased to recognize ...
(Date:6/1/2015)... 01, 2015 Carson Energy also announced ... investors IRA transactions. AdvantaIRA Trust, LLC is the country’s ... ability to fund positions using IRA’s does 2 things:, ... a project, even if there current cash position will ... funding source for Carson and their investors to be ...
(Date:6/1/2015)... York (PRWEB) June 01, 2015 The ... ) has amended the Case Management Order governing ... testosterone gel. The Amended Order which was issued ... on May 29, 2015, directs the parties to submit ... August 10, 2015 that outlines parameters and the process ...
(Date:6/1/2015)... 2015 Atagi Plastic Surgery and Skin ... an Ultherapy® Ultra Treatment Provider by Ulthera, ... Aesthetics is one of only six practices in Colorado ... provider. , Atagi Plastic Surgery and Skin Aesthetics’ ... has led the practice to earn the distinction of ...
Breaking Medicine News(10 mins):Health News:The National Association of Professional Women Inducts Kathy Everette-Gaines, Community Relations Coordinator, Into its VIP Professional Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Lenita F. Cornett, First Sergeant of the US Military, Into its VIP Professional Woman of the Year Circle 2Health News:Carson Energy Brings Oil Wells To IRAs 2Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 2Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 3Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 4Health News:Atagi Plastic Surgery and Skin Aesthetics Named Ultherapy® Ultra Treatment Provider 2
... By Amanda Gardner HealthDay Reporter , TUESDAY, ... belly fat of 10 heart attack patients managed to improve ... is the first time this type of therapy has been ... Tuesday at the American Heart Association,s annual meeting in Chicago. ...
... Steven Reinberg HealthDay Reporter , TUESDAY, Nov. ... advisers were weighing Tuesday whether to recommend the first ... the autoimmune disease lupus. The drug, belimumab (Benlysta), ... treat patients who suffer from systemic lupus erythematosus. ...
... study from the Swedish medical university Karolinska Institutet shows ... aneurysm. These drugs, which block cysteinyl-leukotrienes, could reduce the ... of the aortic wall, and thus the risk of ... the need for complicated and risky surgery. The results ...
... MONDAY, Nov. 15 (HealthDay News) -- It rarely happens, ... and sponges are left inside children undergoing surgery, according to ... mishaps were not more likely to die, but the errors ... long and cost more than double that of the average ...
... The risk of radiation-induced breast cancer from mammography screening ... saved, according to a new study appearing online and in ... "Recently, there have been reports in the press focusing on ... periodic screening," said the study,s lead author, Martin J. Yaffe, ...
... factor 7 (rFVIIa) a drug used to treat ... not recommended because of the potential for adverse events, ... Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj100408.pdf. Recombinant activated factor ... of bleeding in hemophilia patients. It is also used ...
Cached Medicine News:Health News:Study Hints at Stem Cells From Belly Fat as Treatment for Heart Attack 2Health News:Study Hints at Stem Cells From Belly Fat as Treatment for Heart Attack 3Health News:FDA Advisers Consider New Lupus Drug 2Health News:Aortic aneurysm treatable with asthma drugs 2Health News:Sponges, Surgical Tools Sometimes Left in Kids After Operation 2Health News:Sponges, Surgical Tools Sometimes Left in Kids After Operation 3Health News:Radiation fears should not deter women from mammography screening 2Health News:Hemostatic drug less effective than originally predicted 2
(Date:6/1/2015)... 1, 2015  Research Solutions, Inc. (OTCQB: RSSS), a pioneer ... (STM) information for life science companies, academic institutions, and ... at the LD Micro Invitational being held on June ... Los Angeles . ... June 3rd at 9:30 a.m. Pacific time, with one-on-one ...
(Date:6/1/2015)... June 1, 2015 Nevro Corp. (NYSE: ... providing innovative evidence-based solutions for the treatment of chronic ... public offering of its common stock consisting of 1,475,506 ... to be sold by certain of its stockholders. In ... option to purchase up to an additional 590,202 shares ...
(Date:6/1/2015)... British Columbia and MENLO ... -- DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ... on developing and commercializing proven cancer therapies in ... data from its Phase I/II clinical trial of  ... (GBM), the most common and deadly form of ...
Breaking Medicine Technology:Research Solutions to Present at the LD Micro Invitational on June 3, 2015 2Research Solutions to Present at the LD Micro Invitational on June 3, 2015 3Nevro Announces Proposed Public Offering of Common Stock 2Nevro Announces Proposed Public Offering of Common Stock 3DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 2DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 3DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 4DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 5DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 6DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 7DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 8